In-body microgenerator converts heartbeat into electricity for implanted medical devices

Ottawa 11 November 2008A United Kingdom-based consortium of companies has successfully designed and clinically tested an in-body model microgenerator that converts energy from the heartbeat into power for implanted medical devices. Partners in the Self-Energizing Implantable Medical Microsystem (SIMM) project include Zarlink Semiconductor, InVivo Technology Limited, Perpetuum Limited, Finsbury Orthopaedics and Odstock Medical.


The SIMM microgenerator could help power implanted medical devices by augmenting the existing battery for devices such as cardiac pacemakers and implanted cardioverter defibrillators (ICDs). In preclinical testing, the microgenerator successfully produced one-third of the energy required to power a conventional cardiac pacemaker. The consortium is currently discussing next steps for the microgenerator project with medical device manufacturers. Dr. Paul Roberts, consultant electrophysiologist at Southampton University Hospital, United Kingdom, presented details on the SIMM project at the American Heart Association's Scientific Sessions 2008 in New Orleans.

"The microgenerator taps an in-body energy supply - the heartbeat - to help enable more advanced, smaller implanted medical devices that will improve patient care and comfort", stated Martin McHugh, business development manager with Zarlink Semiconductor's Advanced Packaging group and SIMM project co-ordinator. "Taking advantage of a continuous in-body power source, instead of relying solely on batteries, means implanted medical devices supporting advanced diagnostics and therapies can be more easily designed."

Implanted medical devices are increasingly incorporating advanced features in an effort to improve patient care and lower health care costs. For example, cardiac pacemakers are integrating wireless technology to enable home-based health monitoring, with patient health and device performance data transmitted to the physician's office over a broadband network. Wireless technology is also enabling a range of new diagnostics and therapies, including implanted devices used to monitor and treat diabetes and neurostimulators that can alleviate chronic pain or lessen the debilitating effects of Parkinson's disease.

The SIMM microgenerator is a catheter-mounted device that would be placed on a conventional pacemaker or defibrillator lead. The device harvests energy by using differential pressure within the chambers of the heart to drive a linear generator. During testing, the device generated one-third of the power required to run a pacemaker - excluding pacing demand. Next-generation microgenerator devices are expected to fully power both the pacemaker and pacing requirements. Placement of the microgenerator is uncomplicated and is fully compatible with existing techniques for implanting cardiac devices.

"Previous attempts to harvest human energy have resulted in systems that require surgical techniques that pose an unacceptable risk to patients", stated Dr. Paul Roberts. "The SIMM device is designed to be incorporated into a conventional pacemaker or ICD lead, meaning it will not affect current implant procedures for either the cardiologist or patient while delivering a significant clinical benefit. While supporting new applications and functionality, the microgenerator will also improve quality-of-life for patients by enabling smaller devices with a longer operating life."

Announced in December 2006, the SIMM consortium received GBP 560.000 in matched funding from the British government Technology Strategy Board to prototype a device capable of harvesting energy from body movement. The multi-disciplinary consortium is made up of companies chosen for their core engineering skill, product exploitation capability and clinical excellence. The group includes:

  • InVivo Technology which helped to evolve and establish the clinical acceptability and feasibility of proposed energy capture mechanisms;
  • Perpetuum Ltd. which provided the energy-harvesting microgenerator technology;
  • Zarlink Semiconductor which provided advanced micro-packaging techniques at its micro-electronics facility in Caldicot, United Kingdom, and was appointed project leader.

InVivo Technology is a medical technology business, developing intellectual property for innovative health care applications. The company's interests are diverse, ranging from interventional devices and implants to telehealth monitoring and the management of chronic disease.

United Kingdom-based Perpetuum is a world expert in vibration energy harvesting, producing the first commercially available vibration energy harvester for industry, the PMG17. Using normal vibration created by machinery as a source of energy, the PMG17 is an enabling technology for fast growing wireless sensor node applications. Perpetuum innovative power source enables continuous on-line monitoring for pro-active asset management, helping organisations strive towards operational excellence.

For over 30 years, Zarlink Semiconductor has delivered semiconductor solutions that drive the capabilities of voice, enterprise, broadband and wireless communications. The company's success is built on its technology strengths including voice and data networks, opto-electronics and ultra low-power communications. More company news is available in the VMW November 2005 article Given Imaging to launch advanced PillCam SB video capsule.

Leslie Versweyveld

[Medical IT News][Calendar][Virtual Medical Worlds Community][News on Advanced IT]